Title Category Credit Event date Cost
Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team
  • Transplantation
  • Disease Management
  • Oncology
03/23/2020 $0.00 Whether you are just launching your career in the fields of transplantation or oncology or you have been managing transplant or cancer patients for years, this accredited two-day conference is designed to deliver the information you need for the care and management of these patient populations.Faculty consisting of leading medical practitioners from prominent transplant and cancer programs will discuss  the keys to optimize the management/benefits of individuals with cancer and/or undergoing organ or blood/marrow transplant.
Liver Transplantation for Patients with Alcoholic Hepatitis
  • Transplantation
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 Activity descriptionWith advances in the prevention and therapy of viral hepatitis, the percentage of patients with alcohol-associated liver disease requiring liver transplantation is increasing with a growing recognition of liver transplantation as a rescue therapy for individuals with severe alcoholic hepatitis (AH) not responding to medical therapy. Treatment guidelines adopted by most liver transplantation centers require a six-month period of alcohol abstinence and counseling prior to candidacy for liver replacement.
Blood/Marrow Transplant for Autoimmune Disease
  • Transplantation
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionAutoimmune diseases are caused by an overactive immune system that targets the patient’s own cells. Most individuals with autoimmune disorders respond to conventional drug therapies; however, conventional drug therapies are not curative. Although not all autoimmune diseases can be treated with a blood/marrow transplant (BMT), the primary concept underlying use of a BMT for these diseases is that ablating and “resetting” the immune system can alter the disease process.
Updates on Heart Failure Management
  • Transplantation
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionInnovations in Left Ventricular Assist Devices (LVADs) for End-stage Heart Failure
Acute Myelogenous Leukemia: New Therapies after 40 Years!
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionAML is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. With improved biologic understanding of AML and the incorporation of genetic prognostic markers and novel therapeutic options bringing new advancements to the field, individuals with AML have reason to hope. This session will review recent advances and new agents that have been approved for the treatment of AML and discuss the role of biomarkers in AML treatment decisions.
Non-HLA Barriers to Blood/Marrow Transplant
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 Activity descriptionHistorically, the lack of finding a human leukocyte antigens (HLA)-match has been perceived as the largest barrier to blood/marrow transplantation (BMT). Many barriers besides a lack of suitably matched donors exist and can have an adverse impact on access and outcomes of BMT. This session will identify key barriers to BMT including barriers that prevent access to care, such as language and cultural differences; illiteracy; and environmental, geographic, genetic, and medical barriers.
CAR T-cell Therapy: A Personalized Immunotherapy Approach to Cancer
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionWhile chimeric antigen receptor (CAR) T-cell therapy has proven successful in treating certain cancers, severe toxicities have limited its widespread application. This new cancer treatment approach is powerful and does come with serious risks that need to be considered before starting therapy. This session will identify the indications for CAR T-cell therapy and describe the challenges from the toxicities that are unique to CAR T cells. Toxicity management will also be discussed.
Hepatocellular Carcinoma: Treatment Options Outside of Transplant
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionLiver transplantation (LT) is considered the best curative treatment for patients with cirrhosis and hepatocellular carcinoma (HCC) within Milan criteria. Several therapeutic procedures have been proposed as bridging treatments for individuals with HCC awaiting LT. The choice of each treatment is based on: the characteristics of the patient; liver function; comorbidities; and on the number, dimensions, and localization of HCC.
Multiple Myeloma: What’s New in Treatment Options
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionOver the past decade, treatment options for multiple myeloma have increased substantially. New treatments have resulted in improved survival rates among individuals with multiple myeloma. A BMT, in combination with high-dose chemotherapy, is a treatment option that offers a chance for durable remission for individuals with multiple myeloma. Treatment goals can vary significantly from person to person and can have a substantial impact on the type(s) and duration of treatment individuals receive.
Colorectal Cancer: Screening Guidelines and Genetic Biomarker Testing
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionThis activity consists of recorded presentations from the "13th Annual Medical Director/Physician Leadership Forum" held in Austin, Texas, on May 15, 2019.

Pages